The Missing Questions in Psychedelic drug development
Comment for Considerations for Potential Future Use of Psychedelic Drugs Follow up to Testimony at FDA Public Hearing, Sept 14, 2026, Washington, DC
The Missing Question in Psychedelic Drug Development: A TARA4BPD White Paper on Neuroplasticity, Social Learning,
and the Role of Psychedelic Psychotherapy
1 Manifesting the Potential of Psychedelic Treatments
tara4bpd@gmail.com 23 Greene St. NY 10013 valerieattara@gmail.com TEL 917 817 7620 Helpline 1-888-tara napd
TARA4BPD Upcoming SUMMER 2026 Events Register Now
Donate to TARA
